The number of patients with this chronic liver disease, which can lead to permanent liver scarring, eclipses that of hepatitis C in the U.S., RBC’s Yee said. While a significant number aren’t diagnosed, “we believe, based on survey work, that there are hundreds of thousands of patients with diagnosed NASH,” and that the global market for NASH drugs may reach […]
Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.Copyright ©2014 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.
Original link:
2 Biotech Stocks to Buy After Earnings | InvestorPlace
[…]
Last week, earnings remained in focus with several companies reporting their third quarter results. While AbbVie’s (ABBV – Analyst Report) results remained strong with the company raising its outlook, companies like Regeneron (REGN – Analyst Report) and Aegerion (AEGR – Analyst Report) narrowed their sales outlooks for their key products.Among all this, Geron (GERN – Analyst Report) made it to […]
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]
It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]
It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]
That bright neon sign you’re looking at are biotech stocks flashing, “Buy me!”So put down your morning joe. Go ahead, do it. And ignore all incoming e-mail for the next few minutes. Because the biotech breakout has arrived — and it can make you a bundle over the next few months.That’s right. Forget about this month’s stock roller-coaster ride. Yeah, sure, it […]
By Ben LevisohnYes, say the folks at Nomura, who recommend buying Celgene (CELG), Receptos(RCPT), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), and Alexion Pharmaceuticals (ALXN), in that order. Analyst M. Ian Somaiya and team explain why:
October has historically been a weak month for biotech, with the Nasdaq Biotechnology Index underperforming the S&P 500 in 14 out the last 20 years. We believe […]
The Ebola virus has landed in the United States, after Thomas Eric Duncan flew from Liberia to Texas. He was released by a hospital in Dallas, despite telling hospital staff that he came from Liberia. He came in contact with up to 20 people, including 5 schoolchildren since touching down in Dallas. The CDC is monitoring these people, but I have […]
Continue reading –
Shares of PacBio Tripled in 2013 Amid Strong Year for Biotech …
[…]
